Cargando…
New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth
The WHO has declared tuberculosis (TB) a global health emergency. Therefore, there is an urgent need to discover and develop new anti–TB drugs. Here we report on a new category of 5–substituted pyrimidine nucleosides as potent inhibitors of Myco–bacterium tuberculosis growth in vitro. A series of 2ʹ...
Autores principales: | Alexandrova, L.A., Shmalenyuk, E.R., Kochetkov, S.N., Erokhin, V.V., Smirnova, T.G., Andreevskaia, S.N., Chernousova, L.N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347540/ https://www.ncbi.nlm.nih.gov/pubmed/22649636 |
Ejemplares similares
-
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors
por: Alexandrova, Liudmila A., et al.
Publicado: (2022) -
Novel 5′-Norcarbocyclic Pyrimidine Derivatives as Antibacterial Agents
por: Khandazhinskaya, Anastasia L., et al.
Publicado: (2018) -
120 Development of New HIV Inhibitors
por: Kochetkov, S.N.
Publicado: (2014) -
Novel 5′-Norcarbocyclic Derivatives of Bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine Nucleosides
por: Klimenko, Anna A., et al.
Publicado: (2018) -
Investigation of 5’-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents
por: Khandazhinskaya, Anastasia L., et al.
Publicado: (2019)